Elia Ranzato

Prof. Elia Ranzato

Eastern Piedmont University
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2019
Verified
Book Chapter
Closed access
PDF file
SMSimona Martinotti
Simona Martinotti
Elia RanzatoElia Ranzato
Elia Ranzato

15 December 2007 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MPMarco Pedrazzi
Marco Pedrazzi
Mauro PatroneMauro Patrone
Mauro Patrone
MPMario Passalacqua
Mario Passalacqua
Elia RanzatoElia Ranzato
Elia Ranzato
DCDiego Colamassaro
Diego Colamassaro
EMEdon Melloni
Edon Melloni
Extracellular high-mobility group box 1 protein (HMGB1) triggers inflammatory events in the brain. We demonstrate that astrocytes, the main glial cells in the brain, acquire a specific reactive phenotype when exposed to HMGB1. This cell activation, which involves the receptor for advanced glycation end-products and the MAPK/ERK1/2 cascade, results in the transcriptional/translational induction of a restricted number of inflammatory mediators, including cyclooxygenase-2, matrix metalloproteinase-9, and several chemokines of the CC and CXC families. The mixture of factors released by HMGB1-reactive astrocytes displays a potent chemotactic activity on human monocytic cells. This study is the first to suggest that HMGB1/astrocyte interaction plays a specific functional role in the progression of inflammatory processes in the CNS by facilitating local leukocyte infiltration.

1 March 2011 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Elia RanzatoElia Ranzato
Elia Ranzato
SMSimona Martinotti
Simona Martinotti
BBBruno Burlando
Bruno Burlando

6 February 2009 in Planta Medica
Verified
Journal Article
Closed access
PDF file
BBBruno Burlando
Bruno Burlando
Elia RanzatoElia Ranzato
Elia Ranzato
AVAndrea Volante
Andrea Volante
Giovanni AppendinoGiovanni Appendino
Giovanni Appendino
FPFederica Pollastro
Federica Pollastro
Luisella VerottaLuisella Verotta
Luisella Verotta
Five compounds representative of major structural classes of lichen polyketides, viz. (+)-usnic (1), salazinic (2), vulpinic (3), gyrophoric (4), and evernic acids (5), were investigated for their ability to affect cell proliferation or wound healing, two functional targets of relevance for research on cancer or tissue regeneration. The experiments were carried out on MM98 malignant mesothelioma cells, A431 vulvar carcinoma cells, and HaCaT keratinocytes. The NRU and CV cytotoxicity assays showed high toxicity for (+)-usnic acid, intermediate toxicity for vulpinic acid, and low toxicity for salazinic, gyrophoric and evernic acids. Scratch wounding experiments on HaCaT monolayers, in the presence of subtoxic doses of lichen compounds, showed strong wound closure effects by (+)-usnic and gyrophoric acid, an intermediate effect by vulpinic and salazinic acids, and no effect by evernic acid. A combination of (+)-usnic and gyrophoric acids gave a further increase in the wound closure rates. The results of a cell migration test correlated with the wound healing data. In conclusion, (+)-usnic acid might be a particularly interesting compound for the prevention of hyperproliferation syndromes, while (+)-usnic and gyrophoric acids qualify as interesting leads in the promotion of tissue regeneration.

Verified
Journal Article
Open access
PDF file
SMSimona Martinotti
Simona Martinotti
Elia RanzatoElia Ranzato
Elia Ranzato
Honey possesses anti-bacterial, anti-inflammatory and other properties that are useful for wound healing and tissue regeneration. Furthermore, honey has been used for millennia in folk medicine. The misuse of antibiotics has again boosted the use of honey in regenerative medicine. The multifaceted properties of honey could possibly be exploited for scaffold applications in tissue healing.

1 May 2015 in ImmunoTargets and Therapy
Verified
Journal Article
Open access
PDF file
Elia RanzatoElia Ranzato
Elia Ranzato
SMSimona Martinotti
Simona Martinotti
Mauro PatroneMauro Patrone
Mauro Patrone
High-mobility group box 1 (HMGB1) protein is a member of the highly conserved non-histone DNA binding protein family. First identified in 1973, as one of a group of chromatin-associated proteins with high acidic and basic amino acid content, it was so named for its characteristic rapid mobility in polyacrylamide gel electrophoresis. HMGB1 was later discovered to have another function. It is released from a variety of cells into the extracellular milieu to act on specific cell-surface receptors. In this latter role, HMGB1 is a proinflammatory cytokine that may contribute to many inflammatory diseases, including sepsis. Therefore, HMGB1 regulates intracellular cascades influencing immune cell functions, including chemotaxis and immune modulation. The bioactivity of the HMGB1 is determined by specific posttranslational modifications that regulate its role in inflammation and immunity. During tumor development, HMGB1 has been reported to play paradoxical roles in promoting both cell survival and death by regulating multiple signaling pathways. In this review, we focus on the role of HMGB1 in physiological and pathological responses, as well as the mechanisms by which it contributes to immunity, inflammation, and cancer progression.